Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) saw a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 450,400 shares, a growth of 7,665.5% from the September 30th total of 5,800 shares. Based on an average daily trading volume, of 1,810,000 shares, the days-to-cover ratio is presently 0.2 days. Currently, 10.7% of the shares of the company are short sold.
Aditxt Stock Performance
Shares of ADTX opened at $0.84 on Friday. The business has a 50-day simple moving average of $13.88 and a two-hundred day simple moving average of $51.96. Aditxt has a 52 week low of $0.76 and a 52 week high of $380.00.
Aditxt (NASDAQ:ADTX – Get Free Report) last released its earnings results on Monday, August 19th. The company reported ($167.60) earnings per share (EPS) for the quarter. The company had revenue of $0.04 million for the quarter.
Insider Activity at Aditxt
Aditxt Company Profile
Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.
Read More
- Five stocks we like better than Aditxt
- How to buy stock: A step-by-step guide for beginnersÂ
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- What Are Growth Stocks and Investing in Them
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- What Does Downgrade Mean in Investing?
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.